Foundation for Cardiovascular Research, Zurich Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2000
NCT00166257
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 4)

Embolism (Phase 4)

Embolism, Paradoxical (Phase 4)

Foramen Ovale, Patent (Phase 4)

Heart Septal Defects (Phase 4)

Heart Septal Defects, Atrial (Phase 4)

HIV Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3